Shares Outstanding Shares Outstanding n/a Close	832.12M
Shares Change (YoY) Shares Change (YoY) n/a Close	0.06%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	0.01%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	14.21%
Shares Floating Shares Floating n/a Close	832.1M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	1,757
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.09%

Short Selling Information

The latest short interest is 14.23M, so 1.71% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	14.23M
Short % of Shares Out Short % of Shares Out n/a Close	1.71%
Short % of Float Short % of Float n/a Close	3.33%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	10.44

Valuation Ratios

PE Ratio PE Ratio n/a Close	0
Forward PE Forward PE n/a Close	0.23
PS Ratio PS Ratio n/a Close	0
Forward PS Forward PS n/a Close	0
PB Ratio PB Ratio n/a Close	0
P/FCF Ratio P/FCF Ratio n/a Close	0
PEG Ratio PEG Ratio n/a Close	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Dr. Reddy's Laboratories.

EV / Sales EV / Sales n/a Close	n/a
EV / EBITDA EV / EBITDA n/a Close	n/a
EV / EBIT EV / EBIT n/a Close	n/a
EV / FCF EV / FCF n/a Close	n/a

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.14.

Current Ratio Current Ratio n/a Close	1.92
Quick Ratio Quick Ratio n/a Close	1.37
Debt / Equity Debt / Equity n/a Close	0.14
Debt / EBITDA Debt / EBITDA n/a Close	0.48
Debt / FCF Debt / FCF n/a Close	3.89
Interest Coverage Interest Coverage n/a Close	25.4

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity Return on Equity n/a Close	n/a
Return on Assets Return on Assets n/a Close	n/a
Return on Invested Capital Return on Invested Capital n/a Close	n/a
Revenue Per Employee Revenue Per Employee n/a Close	$12,035,455.49
Profits Per Employee Profits Per Employee n/a Close	$2,090,505.77
Employee Count Employee Count n/a Close	27,048
Asset Turnover Asset Turnover n/a Close	0.66
Inventory Turnover Inventory Turnover n/a Close	1.9

Taxes

Income Tax Income Tax n/a Close	19.54B
Effective Tax Rate Effective Tax Rate n/a Close	25.45%

Stock Price Statistics

The stock price has increased by 1.59% in the last 52 weeks. The beta is 0.39, so Dr. Reddy's Laboratories's price volatility has been higher than the market average.

Beta Beta n/a Close	0.39
52-Week Price Change 52-Week Price Change n/a Close	1.59%
50-Day Moving Average 50-Day Moving Average n/a Close	14.52
200-Day Moving Average 200-Day Moving Average n/a Close	14.49
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	54.95
Average Volume (20 Days) Average Volume (20 Days) n/a Close	2,059,329

Income Statement

In the last 12 months, Dr. Reddy's Laboratories had revenue of 325.54B and earned 56.54B in profits. Earnings per share was 0.

Revenue Revenue n/a Close	325.54B
Gross Profit Gross Profit n/a Close	190.43B
Operating Income Operating Income n/a Close	71.84B
Net Income Net Income n/a Close	56.54B
EBITDA EBITDA n/a Close	96.67B
EBIT EBIT n/a Close	79.61B
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	0

Full Income Statement

Balance Sheet

The company has 14.65B in cash and 46.77B in debt, giving a net cash position of -32.11B.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	14.65B
Total Debt Total Debt n/a Close	46.77B
Net Cash Net Cash n/a Close	-32.11B
Retained Earnings Retained Earnings n/a Close	315.79B
Total Assets Total Assets n/a Close	492.99B
Working Capital Working Capital n/a Close	119.72B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 46.43B and capital expenditures -34.4B, giving a free cash flow of 12.03B.

Operating Cash Flow Operating Cash Flow n/a Close	46.43B
Capital Expenditures Capital Expenditures n/a Close	-34.4B
Free Cash Flow Free Cash Flow n/a Close	12.03B
FCF Per Share FCF Per Share n/a Close	0

Full Cash Flow Statement

Margins

Gross margin is 58.5%, with operating and profit margins of 22.07% and 17.37%.

Gross Margin Gross Margin n/a Close	58.5%
Operating Margin Operating Margin n/a Close	22.07%
Pretax Margin Pretax Margin n/a Close	23.59%
Profit Margin Profit Margin n/a Close	17.37%
EBITDA Margin EBITDA Margin n/a Close	29.7%
EBIT Margin EBIT Margin n/a Close	22.07%
FCF Margin FCF Margin n/a Close	3.7%

Dividends & Yields

RDY pays an annual dividend of $0.1, which amounts to a dividend yield of 0.59%.

Dividend Per Share Dividend Per Share n/a Close	$0.10
Dividend Yield Dividend Yield n/a Close	0.59%
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	-1.84%
Payout Ratio Payout Ratio n/a Close	12.28%
Earnings Yield Earnings Yield n/a Close	n/a
FCF Yield FCF Yield n/a Close	n/a

Dividend Details

Analyst Forecast

The average price target for RDY is $16.95, which is 10.6% higher than the current price. The consensus rating is "Strong Buy".

Price Target Price Target n/a Close	$16.95
Price Target Difference Price Target Difference n/a Close	10.6%
Analyst Consensus Analyst Consensus n/a Close	Strong Buy
Analyst Count Analyst Count n/a Close	2

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	n/a
Lynch Upside Lynch Upside n/a Close	-100%
Graham Number Graham Number n/a Close	n/a
Graham Upside Graham Upside n/a Close	n/a

Stock Splits

The last stock split was on Nov 5, 2024. It was a forward split with a ratio of 5:1.

Last Split Date Last Split Date n/a Close	Nov 5, 2024
Split Type Split Type n/a Close	forward
Split Ratio Split Ratio n/a Close	5:1

Scores

Altman Z-Score Altman Z-Score n/a Close	2.42
Piotroski F-Score Piotroski F-Score n/a Close	4